Screener
GT Biopharma GTBP Q4 2025 Annual earnings
Reported March 2, 2026 · After market close
EPS-$2.22Miss by $2.00
EPS estimate-$0.22
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$2.50
Versus estimates
Diluted EPS
FAQ
- When did GT Biopharma report Q4 2025 earnings?
- GT Biopharma (GTBP) reported Q4 2025 earnings on March 2, 2026 after market close.
- What were GT Biopharma's Q4 2025 revenue and EPS?
- GT Biopharma reported eps of $-2.22 for Q4 2025.
- Did GT Biopharma beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.22 by $2.00.
- How did GT Biopharma's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 33.7% from $-1.66.
- Where can I find GT Biopharma's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-26-008442) and the 10-K periodic report (0001493152-26-008443) directly on SEC EDGAR. The filing index links above go to sec.gov.
